Christiana Blair
Brigham and Women's Hospital(US)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, HIV/AIDS drug development and treatment, HIV Research and Treatment, COVID-19 Clinical Research Studies, HIV/AIDS Research and Interventions
Most-Cited Works
- → Remdesivir for 5 or 10 Days in Patients with Severe Covid-19(2020)1,431 cited
- → Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19(2020)1,265 cited
- → Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension(2015)1,135 cited
- → Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial(2016)174 cited
- → Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial(2019)117 cited
- → Effectiveness of Spironolactone Plus Ambrisentan for Treatment of Pulmonary Arterial Hypertension (from the [ARIES] Study 1 and 2 Trials)(2013)106 cited
- → Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension(2013)103 cited
- → Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus(2020)78 cited
- → Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study(2016)71 cited
- → Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis(2020)68 cited